Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera – The Wall Street Journal

Business News

  1. Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera  The Wall Street Journal
  2. Novo Nordisk changes tack with bold raid on Pfizer obesity deal  Reuters
  3. Pfizer Races to Salvage Obesity Drugmaker Deal After Novo’s Bid  Bloomberg.com
  4. Health Care Roundup: Market Talk  The Wall Street Journal
  5. Novo Nordisk bids $9bn for obesity drug maker Metsera in challenge to Pfizer  The Guardian

Source: Business News

/by